1.甘肃省肿瘤医院放疗科 兰州 730050
2.甘肃省肿瘤医院头颈外科 兰州 730050
3.甘肃省肿瘤医院功能科 兰州 730050
董方,女,1981年9月出生,2014年于兰州大学获硕士学位,甘肃省肿瘤医院放疗科副主任医师,从事肿瘤放射治疗工作
薛金才,副主任医师,E-mail: xuejcky@163.com
扫 描 看 全 文
董方, 陶发利, 薛金才, 等. 多模态影像技术在优化头颈鳞癌微小淋巴结放疗中的应用[J]. 辐射研究与辐射工艺学报, 2023,41(3):030306.
DONG Fang, TAO Fali, XUE Jincai, et al. Application of multi-modal imaging technology to optimize radiotherapy of microscopic lymph nodes for head and neck squamous cell carcinoma[J]. Journal of Radiation Research and Radiation Processing, 2023,41(3):030306.
董方, 陶发利, 薛金才, 等. 多模态影像技术在优化头颈鳞癌微小淋巴结放疗中的应用[J]. 辐射研究与辐射工艺学报, 2023,41(3):030306. DOI: 10.11889/j.1000-3436.2023-0002.
DONG Fang, TAO Fali, XUE Jincai, et al. Application of multi-modal imaging technology to optimize radiotherapy of microscopic lymph nodes for head and neck squamous cell carcinoma[J]. Journal of Radiation Research and Radiation Processing, 2023,41(3):030306. DOI: 10.11889/j.1000-3436.2023-0002.
利用多模态影像技术筛选头颈鳞癌患者的颈部微小淋巴结,结合病理结果优化放疗方案,提高患者生存质量。对36例头颈鳞癌患者放疗前行CT或磁共振成像(MRI)检查,选择颈部最长径≤1 cm的微小淋巴结51枚,超声检测相关指标后,在超声引导下行穿刺活检明确病理,根据多模态评价结果勾画靶区并制定放疗计划,评价靶区优化前后的危及器官受照剂量,将检测结果进行差异性比较并观察感兴趣淋巴结区域3 a局控率。腮腺(左、右)的,D,mean,及,V,30,,颌下腺(左、右)的,D,mean,及,V,30,,颌骨的,V,50,,在颈部微小淋巴结靶区优化前后变化较大,,p,<0.05,差异具有显著性意义。治疗结束后随访3 a,共有4例受试者出现高剂量野内颈淋巴结复发,复发率为11.11%,微小淋巴结感兴趣区域未见局部复发。采用多模态影像技术判断头颈鳞癌颈部微小淋巴结良恶性后,进一步优化放疗靶区计划的方法安全可靠。
Multi-modal imaging technology was used to screen the cervical microlymph nodes of patients with head and neck squamous cell carcinoma. Based on the pathological results, radiotherapy was optimized to improve the quality of life of patients. CT or magnetic resonance imaging (MRI) examination before radiotherapy was performed in 36 patients with head and neck squamous cell carcinoma. Fifty-one microlymph nodes with ≤1 cm diameter were selected. Following the ultrasonic detection of relevant indicators, ultrasound-guided puncture biopsy was performed to confirm the pathology. Based on the multi-modal evaluation results, the target area and plan of radiotherapy was confirmed. We evaluated the dose to organs at risk before and after target optimization. The difference in the detection results was compared, and the 3-year local control rate of the lymph node region of interest was observed. The ,D,mean, and ,V,30 ,of the parotid (left and right) and submandibular gland (left and right) and the ,V,50, of the mandibular gland (left and right) had significant differences before and after optimization in the microlymph node target area of the neck,(,p,<,0.05). After 3 years of follow-up, four patients had cervical lymph node recurrence in the high-dose irradiated field. The recurrence rate was 11.11%, and no local recurrence was observed in the microlymph node area of interest. Thus, multi-modal imaging technology is a safe and reliable method to further optimize radiotherapy target planning to distinguish between benign and malignant cervical microlymph nodes of head and neck squamous cell carcinoma.
头颈部鳞状细胞癌微小淋巴结放射治疗
Head and neck squamous cell carcinomaMicrolymph nodeRadiotherapy
Zhao L N, Gong J, Xi Y B, et al. MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma[J]. European Radiology, 2020, 30(1): 537-546. DOI: 10.1007/s00330-019-06211-xhttp://dx.doi.org/10.1007/s00330-019-06211-x.
李思毅, 吴开柳, 陆伟, 等. 早期口腔癌颈部淋巴结处理[J]. 实用肿瘤杂志, 2015, 30(1): 8-11. DOI: 10.13267/j.cnki.syzlzz.2015.01.003http://dx.doi.org/10.13267/j.cnki.syzlzz.2015.01.003.
LI Siyi, WU Kailiu, LU Wei, et al. Management of cervical lymph nodes in early oral cancer[J]. Journal of Practical Oncology, 2015, 30(1): 8-11. DOI: 10.13267/j.cnki.syzlzz.2015.01.003http://dx.doi.org/10.13267/j.cnki.syzlzz.2015.01.003.
Karimi E, Rouhi T, Saeedi N, et al. Occult nodal metastasis in head and neck carcinoma patients treated with chemoradiotherapy[J]. American Journal of Otolaryngology, 2022, 43(2): 103361. DOI: 10.1016/j.amjoto.2021.103361http://dx.doi.org/10.1016/j.amjoto.2021.103361.
Bhandari K, Wang D C, Li S C, et al. Primary cN0 lip squamous cell carcinoma and elective neck dissection: systematic review and meta-analysis[J]. Head & Neck, 2015, 37(9): 1392-1400. DOI: 10.1002/hed.23772http://dx.doi.org/10.1002/hed.23772.
Zhang Y, Yu D L, Yang Q, et al. Diagnostic efficacy of physical examination, preoperative ultrasound, and/or computed tomography in detecting lymph node metastasis: a single-center retrospective analysis of patients with squamous cell carcinoma of the head and neck[J]. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2022, 134(3): 386-396. DOI: 10.1016/j.oooo.2022.05.002http://dx.doi.org/10.1016/j.oooo.2022.05.002.
董诗洁, 胡晓欣, 王葳, 等. 基于多序列MRI与多体系影像组学模型预测子宫颈癌淋巴结转移的研究[J]. 中国癌症杂志, 2021, 31(6): 460-467. DOI: 10.19401/j.cnki. 1007-3639.2021.06.004http://dx.doi.org/10.19401/j.cnki.1007-3639.2021.06.004.
DONG Shijie, HU Xiaoxin, WANG Wei, et al. Prediction of lymph node metastasis of cervical cancer based on multi-sequence MRI and multi-system imaging omics model[J]. China Oncology, 2021, 31(6): 460-467. DOI: 10.19401/j.cnki.1007-3639.2021.06.004http://dx.doi.org/10.19401/j.cnki.1007-3639.2021.06.004.
Li Y X, Su X, Yao F, et al. Comparison of the value of ultrasound and enhanced magnetic resonance imaging in judging cervical lymph node metastasis in patients with oral cancer[J]. Bulletin Du Cancer, 2021, 108(12): 1085-1090. DOI: 10.1016/j.bulcan.2021.09.010http://dx.doi.org/10.1016/j.bulcan.2021.09.010.
任继亮, 宋庆博, 袁瑛, 等. MRI影像组学对早期口腔舌鳞状细胞癌隐匿性颈淋巴结转移的预测价值[J]. 中华放射学杂志, 2022, 56(1): 30-35. DOI: 10.3760/cma.j.cn112149-20211010-00906http://dx.doi.org/10.3760/cma.j.cn112149-20211010-00906.
REN Jiliang, SONG Qingbo, YUAN Ying, et al. Value of MRI radiomics for predicting occult cervical lymph nodes metastases in early-stage oral tongue squamous cell carcinoma[J]. Chinese Journal of Radiology, 2022, 56(1): 30-35. DOI: 10.3760/cma.j.cn112149-20211010-00906http://dx.doi.org/10.3760/cma.j.cn112149-20211010-00906.
覃颖, 康利克, 王小燕, 等. 高频彩色多普勒超声对鼻咽癌颈部淋巴结放疗前后监测的临床探讨[J]. 中国医药指南, 2014, 12(33): 1. DOI: 10.15912/j.cnki.gocm. 2014.33.001http://dx.doi.org/10.15912/j.cnki.gocm.2014.33.001.
QIN Ying, KANG Like, WANG Xiaoyan, et al. High frequency color Doppler flow imaging (CDFI) in nasopharyngeal carcinoma radiotherapy to the cervical lymph nodes before and after the monitoring of clinical study[J]. Guide of China Medicine, 2014, 12(33): 1. DOI: 10.15912/j.cnki.gocm.2014.33.001http://dx.doi.org/10.15912/j.cnki.gocm.2014.33.001.
李龙浩, 蒋娟, 谭本旭, 等. 头颈部鳞癌颈部淋巴结转移放疗残留灶超声特征的logistic回归模型分析[J]. 现代医药卫生, 2016, 32(12): 1789-1791. DOI: 10.3969/j.issn. 1009-5519.2016.12.004http://dx.doi.org/10.3969/j.issn.1009-5519.2016.12.004.
LI Longhao, JIANG Juan, TAN Benxu, et al. Analysis on Logistic regression model of ultrasonographic features of neck lymph node metastasis residual lesions after radiotherapy in head and neck squamous cell carcinoma[J]. Journal of Modern Medicine & Health, 2016, 32(12): 1789-1791. DOI: 10.3969/j.issn.1009-5519.2016.12.004http://dx.doi.org/10.3969/j.issn.1009-5519.2016.12.004.
AlTuwaijri A A, Alessa M A, Abuhaimed A A, et al. Lymph node yield as a prognostic factor in clinically node negative oral cavity squamous cell carcinoma[J]. Saudi Medical Journal, 2021, 42(12): 1357-1361. DOI: 10.15537/smj.2021.42.12.20210572http://dx.doi.org/10.15537/smj.2021.42.12.20210572.
Han M, Kang R, Zhang C. Lymph node mapping for tumor micrometastasis[J]. ACS Biomaterials Science & Engineering, 2022, 8(6): 2307-2320. DOI: 10.1021/acsbiomaterials.2c00111http://dx.doi.org/10.1021/acsbiomaterials.2c00111.
Bugter O, Aaboubout Y, Algoe M, et al. Detecting head and neck lymph node metastases with white light reflectance spectroscopy; a pilot study[J]. Oral Oncology, 2021, 123: 105627. DOI: 10.1016/j.oraloncology.2021. 105627http://dx.doi.org/10.1016/j.oraloncology.2021.105627.
Zhao J, Li X D, Wang M, et al. Diagnostic value of MRI combined with CXCR4 expression level in lymph node metastasis head and neck squamous cell carcinoma[J]. Computational and Mathematical Methods in Medicine, 2022, 2022: 4073918. DOI: 10.1155/2022/4073918http://dx.doi.org/10.1155/2022/4073918.
徐艺, 张烨, 易俊林. 声门上型喉癌根治性放疗颈部预防照射的靶区勾画[J]. 中华放射肿瘤学杂志, 2020, 29(11): 1003-1007. DOI: 10.3760/cma.j.cn113030-20190805-00307http://dx.doi.org/10.3760/cma.j.cn113030-20190805-00307.
XU Yi, ZHANG Ye, YI Junlin. Delineation of prophylactic cervical target volumes in radical radiotherapy for supraglottic laryngeal carcinoma[J]. Chinese Journal of Radiation Oncology, 2020, 29(11): 1003-1007. DOI: 10.3760/cma.j.cn113030-20190805-00307http://dx.doi.org/10.3760/cma.j.cn113030-20190805-00307.
问静, 王丽君, 张兰芳, 等. 鼻咽癌N1患者对侧下颈调强靶区优化的临床研究[J]. 肿瘤学杂志, 2019, 25(2): 102-106. DOI: 10.11735/j.issn.1671-170X.2019.02.B006http://dx.doi.org/10.11735/j.issn.1671-170X.2019.02.B006.
WEN Jing, WANG Lijun, ZHANG Lanfang, et al. Clinical study of contralateral lower neck intensity-modulated radiotherapy target volumn optimization in patients with N1-staged nasopharyngeal carcinoma[J]. Journal of Chinese Oncology, 2019, 25(2): 102-106. DOI: 10.11735/j.issn.1671-170X.2019.02.B006http://dx.doi.org/10.11735/j.issn.1671-170X.2019.02.B006.
van den Bosch S, Vogel W V, Raaijmakers C P, et al. Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation[J]. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, 2018, 128(3): 472-478. DOI: 10.1016/j.radonc.2018.04.020http://dx.doi.org/10.1016/j.radonc.2018.04.020.
张涛, 徐海亭, 许晶, 等. 口咽癌放疗中颈部Ⅱ区和口腔靶区优化对涎腺功能及口腔黏膜反应的影响[J]. 肿瘤研究与临床, 2022, 34(2): 120-123. DOI: 10.3760/cma.j.cn115355-20210526-00234http://dx.doi.org/10.3760/cma.j.cn115355-20210526-00234.
ZHANG Tao, XU Haiting, XU Jing, et al. Effects of cervical regionⅡand oral target area optimization on salivary gland function and oral mucosal response during radiotherapy for oropharyngeal carcinoma[J]. Cancer Research and Clinic, 2022, 34(2): 120-123. DOI: 10.3760/cma.j.cn115355-20210526-00234http://dx.doi.org/10.3760/cma.j.cn115355-20210526-00234.
Jensen S B, Vissink A, Limesand K H, et al. Salivary gland hypofunction and xerostomia in head and neck radiation patients[J]. Journal of the National Cancer Institute Monographs, 2019, 2019(53): lgz016. DOI: 10. 1093/jncimonographs/lgz016http://dx.doi.org/10.1093/jncimonographs/lgz016.
Vistoso Monreal A, Polonsky G, Shiboski C, et al. Salivary gland dysfunction secondary to cancer treatment[J]. Frontiers in Oral Health, 2022, 3: 907778. DOI: 10. 3389/froh.2022.907778http://dx.doi.org/10.3389/froh.2022.907778.
Warwas B, Cremers F, Gerull K, et al. Risk factors for xerostomia following radiotherapy of head-and-neck cancers[J]. Anticancer Research, 2022, 42(5): 2657-2663. DOI: 10.21873/anticanres.15743http://dx.doi.org/10.21873/anticanres.15743.
Zhou N, Chu C, Dou X, et al. Early changes of irradiated parotid glands evaluated by T1rho-weighted imaging: a pilot study[J]. Journal of Computer Assisted Tomography, 2017, 41(3): 472-476. DOI: 10.1097/RCT. 0000000000000547http://dx.doi.org/10.1097/RCT.0000000000000547.
岑妍芳, 李媛媛, 金风. 调强放疗时代头颈部肿瘤腮腺组织损伤的认识及研究进展[J]. 肿瘤预防与治疗, 2019, 32(7): 638-644. DOI: 10.3969/j.issn.1674-0904. 2019.07.013http://dx.doi.org/10.3969/j.issn.1674-0904.2019.07.013.
CEN Yanfang, LI Yuanyuan, JIN Feng. Understanding and research progress of parotid gland tissue injury in patients with head and neck cancer in the era of intensity-modulated radiotherapy[J]. Journal of Cancer Control and Treatment, 2019, 32(7): 638-644. DOI: 10.3969/j.issn. 1674-0904.2019.07.013http://dx.doi.org/10.3969/j.issn.1674-0904.2019.07.013.
Zheng L R, Wang H, Yang N, et al. Research value of intensity modulated radiation therapy in alleviating parotid gland function injury in patients with stage N0 nasopharyngeal carcinoma from physical and dosimetric aspects[J]. Computational and Mathematical Methods in Medicine, 2022, 2022: 4651364. DOI: 10.1155/2022/4651364http://dx.doi.org/10.1155/2022/4651364.
Bandlamudi B P, Sharan K, Yathiraj P H, et al. A study on the impact of patient-related parameters in the ability to spare parotid glands by intensity-modulated radiotherapy for head and neck squamous cell carcinomas[J]. Journal of Cancer Research and Therapeutics, 2018, 14(6): 1220-1224. DOI: 10.4103/jcrt.JCRT_362_16http://dx.doi.org/10.4103/jcrt.JCRT_362_16.
Rades D, Warwas B, Gerull K, et al. Prognostic factors for complete recovery from xerostomia after radiotherapy of head-and-neck cancers[J]. In Vivo (Athens, Greece), 2022, 36(4): 1795-1800. DOI: 10.21873/invivo.12894http://dx.doi.org/10.21873/invivo.12894.
Sim C, Soong Y L, Pang E, et al. Xerostomia, salivary characteristics and gland volumes following intensity-modulated radiotherapy for nasopharyngeal carcinoma: a two-year follow up[J]. Australian Dental Journal, 2018, 63(2): 217-223. DOI: 10.1111/adj.12608http://dx.doi.org/10.1111/adj.12608.
0
浏览量
10
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构